Endothelial connexin 32 regulates tissue factor expression induced by inflammatory stimulation and direct cell-cell interaction with activated cells

Atherosclerosis

Volumn 236, Issue 2, 2014, Pages 430-437

  Okamoto, Takayuki ^a   Akita, Nobuyuki ^b   Hayashi, Tatsuya ^c   Shimaoka, Motomu ^a   Suzuki, Koji ^a,b  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c MIE PREFECTURAL COLLEGE OF NURSING   (Japan)

Author keywords

Cell cell interaction; Connexin; Endothelial cell; Gap junction; Inflammation; Tissue factor

Indexed keywords

CONNEXIN 32; FC RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MONOCLONAL ANTIBODY; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY CONJUGATE; CARBENOXOLONE; GAP JUNCTION PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; OLEIC ACID; OLEYLAMIDE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL COMMUNICATION; CELL INTERACTION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GAP JUNCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULITIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BLOOD CLOTTING; CELL CULTURE; COCULTURE; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD COAGULATION; CARBENOXOLONE; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CONNEXINS; ENDOTHELIAL CELLS; GAP JUNCTIONS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FC FRAGMENTS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICE; MICE, KNOCKOUT; OLEIC ACIDS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 84907084861     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.07.025     Document Type: Article

References (42)

1. Kumar N.M., Gilula N.B. The gap junction communication channel. Cell 1996, 84:381-388.
2. Saez J.C., Berthoud V.M., Branes M.C., et al. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003, 83:1359-1400.
3. Willecke K., Eiberger J., Degen J., et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002, 383:725-737.
4. Oyamada M., Oyamada Y., Takamatsu T. Regulation of connexin expression. Biochim Biophys Acta 2005, 1719:6-23.
5. Brisset A.C., Isakson B.E., Kwak B.R. Connexins in vascular physiology and pathology. Antioxid Redox Signal 2009, 11:267-282.
6. Wong C.W., Christen T., Roth I., et al. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 2006, 12:950-954.
7. Kwak B.R., Veillard N., Pelli G., et al. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 2003, 107:1033-1039.
8. Haefliger J.A., Krattinger N., Martin D., et al. Connexin43-dependent mechanism modulates renin secretion and hypertension. J Clin Invest 2006, 116:405-413.
9. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002, 347:1916-1923.
10. van Rijen H.V., van Kempen M.J., Postma S., et al. Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine 1998, 10:258-264.
11. Kwak B.R., Mulhaupt F., Veillard N., et al. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002, 22:225-230.
12. Vorderwulbecke B.J., Maroski J., Fiedorowicz K., et al. Regulation of endothelial connexin-40 expression by shear stress. Am J Physiol Heart Circ Physiol 2012, 302:H143-H152.
13. Scheckenbach K.E., Crespin S., Kwak B.R., et al. Connexin channel-dependent signaling pathways in inflammation. J Vasc Res 2011, 48:91-103.
14. Okamoto T., Akiyama M., Takeda M., et al. Connexin32 protects against vascular inflammation by modulating inflammatory cytokine expression by endothelial cells. Exp Cell Res 2011, 317:348-355.
15. Chadjichristos C.E., Scheckenbach K.E., van Veen T.A., et al. Endothelial-specific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion. Circulation 2010, 121:123-131.
16. Okamoto T., Akiyama M., Takeda M., et al. Connexin32 is expressed in vascular endothelial cells and participates in gap-junction intercellular communication. Biochem Biophys Res Commun 2009, 382:264-268.
17. Nemerson Y. Tissue factor and hemostasis. Blood 1988, 71:1-8.
18. Wada H., Wakita Y., Shiku H. Tissue factor expression in endothelial cells in health and disease. Blood Coagul Fibrinolysis 1995, 6(Suppl. 1):S26-S31.
19. Fleck R.A., Rao L.V., Rapaport S.I., et al. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990, 59:421-437.
20. Drake T.A., Morrissey J.H., Edgington T.S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J pathol 1989, 134:1087-1097.
21. Callander N.S., Varki N., Rao L.V. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992, 70:1194-1201.
22. Deguchi H., Takeya H., Wada H., et al. Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes. Blood 1997, 90:2345-2356.
23. Galdal K.S., Lyberg T., Evensen S.A., et al. Thrombin induces thromboplastin synthesis in cultured vascular endothelial cells. Thromb Haemost 1985, 54:373-376.
24. Scarpati E.M., Sadler J.E. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J biol Chem 1989, 264:20705-20713.
25. Archipoff G., Beretz A., Freyssinet J.M., et al. Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester. Biochem J 1991, 273(Pt 3):679-684.
26. Steffel J., Luscher T.F., Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 2006, 113:722-731.
27. Breitenstein A., Tanner F.C., Luscher T.F. Tissue factor and cardiovascular disease: quo vadis?. Circ J 2010, 74:3-12.
28. Annex B.H., Denning S.M., Channon K.M., et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995, 91:619-622.
29. Wilcox J.N., Smith K.M., Schwartz S.M., et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 1989, 86:2839-2843.
30. Gho Y.S., Kleinman H.K., Sosne G. Angiogenic activity of human soluble intercellular adhesion molecule-1. Cancer Res 1999, 59:5128-5132.
31. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170:191-203.
32. Derouette J.P., Wong C., Burnier L., et al. Molecular role of Cx37 in advanced atherosclerosis: a micro-array study. Atherosclerosis 2009, 206:69-76.
33. Isakson B.E., Duling B.R. Heterocellular contact at the myoendothelial junction influences gap junction organization. Circulation Res 2005, 97:44-51.
34. Heberlein K.R., Straub A.C., Isakson B.E. The myoendothelial junction: breaking through the matrix?. Microcirculation 2009, 16:307-322.
35. Straub A.C., Billaud M., Johnstone S.R., et al. Compartmentalized connexin 43 s-nitrosylation/denitrosylation regulates heterocellular communication in the vessel wall. Arterioscler Thromb Vasc Biol 2011, 31:399-407.
36. Katakowski M., Buller B., Wang X., et al. Functional microRNA is transferred between glioma cells. Cancer Res 2010, 70:8259-8263.
37. Giepmans B.N. Gap junctions and connexin-interacting proteins. Cardiovasc Res 2004, 62:233-245.
38. Lawson C., Wolf S. ICAM1 signaling in endothelial cells. Pharmacol Rep 2009, 61:22-32.
39. Blann A.D., Woywodt A., Bertolini F., et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005, 93:228-235.
40. Chironi G.N., Boulanger C.M., Simon A., et al. Endothelial microparticles in diseases. Cell Tissue Res 2009, 335:143-151.
41. Curtis A.M., Wilkinson P.F., Gui M., et al. p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles. J Thromb Haemost 2009, 7:701-709.
42. Furie B., Furie B.C. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 2004, 10:171-178.